跳至主要内容
临床试验/IRCT20200317046801N1
IRCT20200317046801N1已完成3 期

Evaluation of the effect of vitamin B6 as adjunctive therapy in ameliorating symptoms of acute mania in patients with bipolar disorder Type 1 hospitalized in Roozbeh Hospital; a double-blind placebo-controlled clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Subjects aged 18 to 65 years old
  • Diagnosis of type 1 bipolar disorder in early-onset mania based on DSM-V diagnostic criteria (by semi-structured interview by a psychiatrist and confirmation of diagnosis with a score of at least 20 on the Young Mania Scale).
  • Consent of the possibility of being present on the patient's legal guardian

排除标准

  • Absence of psychosis in patients
  • A history of drug sensitivity to lithium carbonate or vitamin B6
  • Absence of diagnoses of schizophrenia, delirium, anorexia neurosis, bulimia neurosis, autism, substance abuse (at least 3 months ago), retardation Bipolar type 2 seizures (Existence of suicide due to lack of suicide risk factor for use of evaluated drugs as well as weekly weekly medications and low weekly prescription drugs are not included in the plan).

研究者

相似试验